Sign Up to like & get
recommendations!
0
Published in 2017 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2017.1284659
Abstract: ABSTRACT Introduction: Lenalidomide, first introduced for the treatment of multiple myeloma in 2008, has been used in the treatment of various subtypes of non-Hodgkin lymphoma (NHL). Considering its mechanism of action, it has been associated…
read more here.
Keywords:
lymphoma;
combination;
review lenalidomide;
lenalidomide therapy ... See more keywords